Petlife Pharmaceuticals, Inc. (PTLF: OTCQB) | PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.
(0)
(0)